1. Field of the Invention
Embodiments of this invention relates to reusable high performance water based drilling fluids.
In particular, embodiments of this invention relates to reusable high performance water based drilling fluids, where the fluids include a water based continuous aqueous phase and discontinuous non-aqueous phase, where the aqueous phase is a brine and the non-aqueous phase is composed of glycerols, polyglycerols, poly hydroxyl alcohols, poly hydroxyl alcohols, monosaccharide derivatives, polysaccharide derivatives, or mixtures and combinations thereof.
2. Description of the Related Art
Oil based drilling fluids have historically been the preferred choice for exploration and development of drilling projects. These fluids are often reused from well to well and guarantee among other things: reasonable costs, good inhibiting properties, and good lubricity properties. Against these advantages, there are several disadvantages including high environmental impact such as spillage risks, significant cuttings disposal costs and location remedial costs. These fluids also entail logistics issues in moving large volumes of organic base fluids and salts, increased costs on solids control equipments and an undesirable dependency on the type of organic base fluids chosen for a given project.
Many principles have been addressed to control shale hydration due to drilling fluids used in the oil industry. Some of these control technologies include the use of lime and gypsum calcic fluids, salts dissolved in the aqueous phase up to saturation, silicate fluids, shale encapsulating polymers, amines, amphoteric polymers, inverted emulsion fluids, pore pressure transmission blocking mechanisms, glycol based fluids and many intermediate combinations of the above. Most fluids are based on one principle and often fail to address geological conditions and environmental regulation.
Historically, water based fluids have been a one interval disposable volume. Thus, there is a need in the art for reusable high performance water based drilling fluids.
Embodiments of the present invention provide different inhibition mechanisms to cope with reactive formations such as a formation including swellable clays. The present compositions emulate oil based fluids by having an organic internal phase, which creates an osmotic membrane. The osmotic membrane allows hydration-dehydration mechanisms to be in place and control interactions between the formation and the fluid. The non-aqueous phase, on the inhibition side, comprises or is composed of glycerols, polyglycerols, poly hydroxyl alcohols, monosaccharide derivatives, polysaccharide derivatives, or mixtures and combinations thereof, while the aqueous phase contains ingredients to impart different inhibiting mechanisms to the overall composition, where the ingredients and/or mechanisms include, without limitation, amphoteric polymers, potassium and/or sodium salts of up to saturation and/or polyacrylamides. In certain embodiments, the compositions may also include silicates. The compositions of this invention allow the drilled cuttings to travel up the annular gap, avoiding dissolution. Also fluid dilution is minimized. Pore pressure transmission blocking mechanisms are present in the fluids enhancing well stability and widening the pressure window between hydrostatic pressure and fracture gradient. The fluids have low environmental impact, which will save on solids control equipment requirements and will minimize disposal and remedial costs.
Embodiments of the present invention also provide methods for making or preparing compositions of this invention.
Embodiments of the present invention also provide methods for drilling a borehole comprising circulating, e.g., in the borehole, a composition of the present invention.
Embodiments of the present invention also provider reusable high performance water based drilling fluids and other reusable high performance water based downhole fluids having low toxicity and reduced environmental impact. This reduces operating costs by improving material logistics and providing high drilling performance to operators.
The inventors have found that a reusable high performance water based fluids may be formulated having a full range of densities. The reusable high performance water based fluids include a continuous aqueous phase and a discontinuous organic or non-aqueous phase forming an osmotic membrane. The aqueous phase comprises a brine having certain controlled properties and the non-aqueous phase comprises glycerols, polyglycerols, poly hydroxyl alcohols, monosaccharide derivatives, polysaccharide derivatives, or mixtures and combinations thereof. The term reusable, in the context of oil-based drilling muds or fluids, means that when a particular drilling job is finished or completed, the mud or drilling fluid may be stored in tanks until it is needed for drilling another well. The fluids of this invention remain complete, high performance water based drilling fluids that may be used over and over again for drilling. The drilling fluids of this invention, therefore, are capable of being used from job to job, with make-up fluid volume being added as needed and drilling fluid treatments made to the drilling fluids of this invention to maintain, modify, and/or alter desired fluid properties.
The inventors have found that by using a storage facility nearby the location in between jobs, the water based fluid may be rendered reusable. The present fluids will reduce liability for environmental integrated projects.
The inventors have also found that reusable high performance water based fluids may be formulated having density over a wide density range. In certain embodiments, the density of the fluids ranges between about 8.6 ppg and one 20 ppg and the fluids may be formulated for both low, moderate, and high temperature applications. In certain embodiments, the density of the fluids is between about 8.6 ppg and 18 ppg. In other embodiments, the density of the fluids is between about 8.6 ppg and 16 ppg. In other embodiments, the density of the fluids is between about 8.6 ppg and 14 ppg. In other embodiments, the density of the fluids is between about 8.6 ppg and 12 ppg. In other embodiments, the density of the fluids is between about 8.6 ppg and 10 ppg. The term “ppg” will be herein understood to mean “pounds per gallon”.
Multi-functional additives have been developed that improve drilling fluid lubricity as well as a penetration rate and improve inhibiting properties of reactive shale. The new additives have been used at various volume % (vol. %) concentrations, based on the total fluid composition, e.g., drilling fluid composition, in formulations having varying densities. In certain embodiments, the concentration is at least 5% by volume. In certain embodiments, the concentration is at least 10% by volume. In certain embodiments, the concentration is at least 16% by volume. In certain embodiments, the concentration is at least 18% by volume. In certain embodiments, the concentration is up to 20% by volume.
In certain embodiments, the compositions include from about 51 wt. % to about 95 wt. % of the aqueous phase and from about 5 wt. % to about 49 wt. % of the non-aqueous phase. In other embodiments, the compositions include from about 55 wt. % to about 95 wt. % of the aqueous phase and from about 5 wt. % to and about 45 wt. % of the non-aqueous phase. In other embodiments, the compositions include from about 60 wt. % to about 95 wt. % of the aqueous phase and from about 5 wt. % to and about 40 wt. % of the non-aqueous phase. In other embodiments, the compositions include from about 65 wt. % to about 95 wt. % of the aqueous phase and from about 5 wt. % to and about 35 wt. % of the non-aqueous phase. In other embodiments, the compositions include from about 75 wt. % to about 95 wt. % of the aqueous phase and from about 5 wt. % to about 25 wt. % of the non-aqueous phase.
Embodiments of this invention broadly relate to reusable fluid compositions including (a) an aqueous continuous phase including an additive composition to change certain properties of the aqueous continuous phase, where the additive composition comprises amphoteric polymers, salts up to saturation, polyacrylamides, and mixtures or combinations thereof, and (b) an organic internal phase including glycerols, polyglycerols, poly hydroxyl alcohols, monosaccharide derivatives, polysaccharide derivatives, or mixtures and combinations thereof, where the organic internal phase forms an osmotic membrane within the continuous aqueous phase and where the osmotic membrane allows hydration-dehydration mechanisms to be in place and control interactions between formation and fluid. In other embodiments, the additive composition includes hydratable polymers. In other embodiments, the additive composition includes a humalite product, high molecular weight xanthan gum and/or a complex mixture of natural polysaccharides, high-quality, low-viscosity, sodium salt of carboxymethyl celluloses, polyanionic cellulose, glycol-based anti-foaming agents, white calcium carbonate, barium sulfate mineral, and/or shale inhibitor. Humalite may be described as a natural derivative from sub-bituminous coal, containing substances such as humic acid, fulvic acid and/or humin. In other embodiments, the compositions have a density between about 8.6 ppg and about 20 ppg. In other embodiments, the compositions have a density between about 8.6 ppg and about 18 ppg. In other embodiments, the aqueous phase is present in an amount between about 51 wt. % and about 95 wt. % and the non-aqueous phase is present in an amount between about 5 wt. % and about 49 wt. %. In other embodiments, the aqueous phase is present in an amount between about 55 wt. % and about 95 wt. % and the non-aqueous phase is present in an amount between about 5 wt. % and about 45 wt. %. In other embodiments, the aqueous phase is present in an amount between about 65 wt. % and about 95 wt. % and the non-aqueous phase is present in an amount between about 5 wt. % and about 35 wt. %. In other embodiments, the aqueous phase comprises a brine. In other embodiments, the brine comprises a fresh water brine formed by adding the salts to fresh water.
Embodiments of this invention broadly relates to reusable drilling fluid compositions including (a) an aqueous continuous phase including an additive composition to change certain properties of the aqueous continuous phase, where the additive composition includes amphoteric polymers, salts up to saturation, polyacrylamides, or mixtures and combinations thereof, and (b) an organic internal phase including glycerols, polyglycerols, poly hydroxyl alcohols, monosaccharide derivatives, polysaccharide derivatives, or mixtures and combinations thereof, where the organic internal phase creates an osmotic membrane within the continuous aqueous phase and where the osmotic membrane allows hydration-dehydration mechanisms to be in place and control interactions between formation and fluid. In certain embodiments, the compositions have a density between about 8.6 ppg and about 20 ppg. In other embodiments, the compositions have a density between about 8.6 ppg and about 18 ppg. In other embodiments, the aqueous phase is present in an amount between about 51 wt. % and about 95 wt. % and the non-aqueous phase is present in an amount between about 5 wt. % and about 49 wt. %. In other embodiments, the aqueous phase is present in an amount between about 55 wt. % and about 95 wt. % and the non-aqueous phase is present in an amount between about 5 wt. % and about 45 wt. %. In other embodiments, the aqueous phase is present in an amount between about 65 wt. % and about 95 wt. % and the non-aqueous phase is present in an amount between about 5 wt. % and about 35 wt. %. In other embodiments, the aqueous phase comprises a brine. In other embodiments, the brine comprises a fresh water brine formed by adding the salts to fresh water.
Embodiments of this invention broadly relates to methods for drilling a borehole including the step of (a) while drilling, circulating a fluid composition of this invention. The fluid composition comprises (a) an aqueous continuous phase including an additive composition to change certain properties of the aqueous continuous phase, where the additive composition comprises amphoteric polymers, salts up to saturation, polyacrylamides or mixtures and combinations thereof, and (b) an organic internal phase including glycerols, polyglycerols, poly hydroxyl alcohols, monosaccharide derivatives, polysaccharide derivatives, or mixtures and combinations thereof, where the organic internal phase creates an osmotic membrane within the continuous aqueous phase, where the osmotic membrane allows hydration-dehydration mechanisms to be in place and control interactions between formation and fluid and where the drilling fluid composition is reusable and the fluid has improved lubricity and improved cutting lift properties. In certain embodiments, the compositions have a density between about 8.6 ppg and about 20 ppg. In other embodiments, the compositions have a density between about 8.6 ppg and about 18 ppg. In other embodiments, the aqueous phase is present in an amount between about 51 wt. % and about 95 wt. % and the non-aqueous phase is present in an amount between about 5 wt. % and about 49 wt. %. In other embodiments, the aqueous phase is present in an amount between about 55 wt. % and about 95 wt. % and the non-aqueous phase is present in an amount between about 5 wt. % and about 45 wt. %. In other embodiments, the aqueous phase is present in an amount between about 65 wt. % and about 95 wt. % and the non-aqueous phase is present in an amount between about 5 wt. % and about 35 wt. %. In other embodiments, the aqueous phase comprises a brine. In other embodiments, the brine comprises a fresh water brine formed by adding the salts to fresh water.
Suitable non-aqueous phase compositions include, without limitation, polyglycerol blends. Exemplary examples include a specific commercial mixture of mono, di, and triglycerins or a polyglycerol blend such as Oxi-Cure products from Cargill, Incorporated including Oxi-Cure 500 bearing CAS#25618-55-7 with synonymous products including glycerol homopolymers, glycerol polymers, polyglycerols, and/or 1,2,3-propanetriol homopolymers. One polyglycerol blend used in the compositions of the present invention had the following specification:
Suitable aqueous phase compositions include, without limitation, sodium brines, potassium brines, calcium brines, other brines, or mixtures and combinations thereof. The brines are made by adding sodium, potassium, and/or calcium salts to water up to saturation. Exemplary examples of sodium, potassium, and/or calcium salts include NaCl, KCl, CaCl2, and/or equivalent sodium, potassium and/or calcium salts.
Suitable polyols, monosaccharides, and/or polysaccharides include, without limitation, six carbon sugars and their derivatives (e.g., allose, altrose, glucose, mannose, gulose, idose, galactose, talose, and cyclic hemiacetals or other derivatives), sorbitol, sorbitan, agar, agarose, alginic acid, alguronic acid, alpha glucan, amylopectin, amylose, arabinoxylan, beta-glucan, biocell collagen, callose, capsulan, carrageenan, cellodextrin, cellulin, cellulose, chitin, chitin nanofibril, chitosan, chrysolaminarin, curdlan, cyclodextrin, deae-sepharose, dextran, dextrin, exopolysaccharide, alpha-cyclodextrin, ficoll, fructan, fucoidan, galactoglucomannan, galactomannan, gellan gum, glucan, glucomannan, glucuronoxylan, glycocalyx, glycogen, hemicellulose, homopolysaccharide, hypromellose, icodextrin, inulin, kefiran, laminarin, lentinan, levan polysaccharide, lichenin, matrixdb, mixed-linkage glucan, mucilage, natural gum, oxidized cellulose, paramylon, pectic acid, pectin, pentastarch, pleuran, polydextrose, polysaccharide peptide, porphyran, pullulan, schizophyllan, selective relaxant binding agent, sepharose, sinistrin, sizofiran, sugammadex, unhydrolysable glucose polymers, welan gum, xanthan gum, xylan, xyloglucan, zymosan or mixtures or combinations thereof.
Suitable hydratable polymers that may be used in embodiments of the invention include any of the hydratable polysaccharides which are capable of forming a gel in the presence of a crosslinking agent. For instance, suitable hydratable polysaccharides include, but are not limited to, xanthan gums, galactomannan gums, glucomannan gums, guars, derived guars, and cellulose derivatives. Specific examples are guar gum, guar gum derivatives, locust bean gum, Karaya gum, carboxymethyl cellulose, carboxymethyl hydroxyethyl cellulose, and hydroxyethyl cellulose. Exemplary examples include, but are not limited to, guar gums, hydroxypropyl guar, carboxymethyl hydroxypropyl guar, carboxymethyl guar, and carboxymethyl hydroxyethyl cellulose. Suitable hydratable polymers may also include synthetic polymers, such as polyvinyl alcohol, polyacrylamides, poly-2-amino-2-methyl propane sulfonic acid, and various other synthetic polymers and copolymers. The hydratable polymer may be present in the fluid in concentrations ranging from about 0.10% to about 5.0% by weight of the aqueous fluid. A preferred range for the hydratable polymer is about 0.20% to about 0.80% by weight.
Suitable amphoteric polymers include, without limitation, branched and/or cross-linked associative amphoteric polymers. The usable branching agents (cross-linking agents) are N-methylol acrylamide, methylene bis acrylamide, allyl ethers of sucrose, diacrylates, divinyls and all other multifunction compounds which can cause branching. One could also use one of the known branching agents for diallylated compounds such as methyl triallyl ammonium chloride, triallylamine, tetraallyl ammonium chloride, tetra allyl oxyethane, tetra allyl ethylene diamine and, more generally, all polyallylated compounds. It is also possible to make post-cross-linked polymers, for example by amidation reaction, esterification reaction, gamma ray treatment, etc.
An example of an amphoteric polymer is described in U.S. Pat. No. 7,700,702 B2. An example of such amphoteric polymer may comprise at least one acrylamide-derived cationic monomer containing a hydrophobic chain and with the general formula:
R1,R2C═CR3CONR4QN+R5R6R7X−
where: R1, R2, R3, R4, R5, and R6 are independently, a hydrogen or an alkyl chain containing 1 to 4, carbons, Q is an alkyl chain containing 1 to 8 carbons, R7 is an alkyl or arylalkyl chain containing 8 to 30 carbons, X is a halide selected from the group including bromide, chloride, iodide, fluoride or a counterion with a negative charge;
between 1 and 99.9 mole % of at least one anionic monomer, and
between 1 and 99 mole % at least one non-ionic hydrosoluble monomer.
The anionic monomers can be selected from a wide group. These monomers may present acrylic, vinyl, maleic, fumaric or allyl functionalities and may contain a carboxy, phosphonate, sulfonate or other group with an anionic charge, or the ammonium salt or alkaline-earth metal salt or alkaline metal salt corresponding to such a monomer. Examples of suitable monomers include acrylic acid, methacrylic acid, itaconic acid, crotonic acid, maleic acid, fumaric acid and strong-acid monomers, for example with a sulfonic or phosphonic acid-type function such as 2-acrylamido-2-methylpropane sulfonic acid, vinylsulfonic acid, vinylphosphonic acid, allylsulfonic acid, allylphosphonic acid, styrene sulfonic acid and their water-soluble salts of an alkali metal, alkaline-earth metal and ammonium.
The at least one non-ionic hydrosoluble monomer can be selected from the group including water-soluble vinyl monomers. In certain embodiments, the monomers belonging to this category are advantageously selected from the group including acrylamide and methacrylamide, N-isopropylacrylamide, N,N-dimethylacrylamide and N-methylolacrylamide. N-vinylformamide, N-vinyl acetamide, N-vinylpyridine and/or N-vinylpyrrolidone can also be used. Acrylamide may be the preferred non-ionic monomer.
Other amphoteric polymers include polymers having between 0.005 and 10 mole % hydrophobic cationic monomers, between 5 and 90 mole % of at least one anionic monomer, advantageously acrylic acid and/or methacrylic acid and/or 2-acrylamido-2-methylpropane sulfonic acid and their salts; and between 5 and 90 mole % of at least one hydrosoluble non-ionic monomer, advantageously acrylamide and/or methacrylamide and/or N-isopropylacrylamide and/or N,N-dimethylacrylamide and/or N-vinylformamide and/or N-vinyl acetamide and/or N-vinylpyrrolidone. Other polymers contain between 0.01 and 5 mole % of hydrophobic monomers and between 10 and 60 mole % of an anionic monomer and between 35 and 90 mole % of a non-ionic monomer. Other polymers contain between 0.02 and 2 mole % of hydrophobic monomers and between 10 and 50 mole % of an anionic monomer: acrylic acid, methacrylic acid and/or 2-acrylamido-2-methylpropane sulfonic acid and their salts, and between 48 and 90 mole % of a non-ionic monomer: acrylamide and/or methacrylamide and/or N-isopropylacrylamide and/or N,N-dimethylacrylamide and/or N-vinylformamide and/or N-vinyl acetamide and/or N-vinylpyrrolidone. Other polymers include acrylamide-derived hydrophobic cationic monomers preferred for the invention are N-acrylamidopropyl-N,N-dimethyl-N-dodecyl ammonium chloride (DMAPA Cl(C12)), N-methacrylamidopropyl-N,N-dimethyl-N-dodecyl ammonium chloride (DMAPMA Cl(C12)), N-acrylamidopropyl-N,N-dimethyl-N-dodecyl ammonium bromide (DMAPA Br(C12)), N-methacrylamidopropyl-N,N-dimethyl-N-dodecyl ammonium bromide (DMAPMA Br(C12)), N-acrylamidopropyl-N,N-dimethyl-N-octadecyl ammonium chloride (DMAPA Cl(C18)), N-methacrylamidopropyl-N,N-dimethyl-N-octadecyl ammonium chloride (DMAPMA Cl(C18)), N-acrylamidopropyl-N,N-dimethyl-N-octadecyl ammonium bromide (DMAPA Br(C18)), N-methacrylamidopropyl-N,N-dimethyl-N-octadecyl ammonium bromide (DMAPMA Br(C18)).
Suitable silicates that may be used in the fluids of this invention include, without limitation, hydrated or anhydrous silicate minerals with a layered structure and include, for example, alumino-silicate clays such as kaolins including hallyosite, smectites including montmorillonite, illite, and the like. Exemplary silicates include those marketed under the tradename CLOISITE® marketed by Southern Clay Additives, Inc. In an embodiment, silicates are exfoliated to separate individual sheets, or are non-exfoliated. Other silicates of similar structure can also be included such as, for example, talc, micas including muscovite, phlogopite, or phengite, or the like.
This example illustrates the preparation of reusable high performance water based drilling fluid having a density of 10 ppg.
18.0 wt. % of sorbitol powder was dissolved in 23.3 wt. % deionized water. The resulting aqueous solution was then mixed into 56.7 wt. % of a polyglycerol blend such as Oxi-Cure 500 and mixing was continued until fluid was completely blended. To this fluid, 2.0 wt. % of a 50 wt. % KOH solution (1.0% equivalent KOH) was added. The KOH was added to the 13.1 wt. % NaCl brine, then pre-solubilize the 10 ppb HUMALITE in the aqueous mixture. The resulting polyglycerol blend was used successfully at a 14% concentration level in 10 ppg and 12 ppg formulations of a 13.1% by weight NaCl water-base system. The initial pH was 12.34 at 72.2° F. The pH after 30 days was 11.22 at 71.0° F. The pH after 71 days was 9.84 at 71.0° F.
The neat composition of Example 1 was a viscous liquid and had a brownish amber color, a specific gravity between 1.23 and 1.28, a density in pounds per gallon (ppg) between 10.26 ppg and 10.68 ppg, a flash point >392° F. (>200° C.), a pH between 9.5 and 10.5, mild odor, and freeze point <−36.4° F. (<−38° C.).
Example 1 had a pH:13.17 @ 68.8° F., a specific gravity of 1.24, and a brownish amber color. The freezing point of the composition was supposed to be −38° F. When the sample was left in the chiller for 24 hours at −38° F., the sample was very thick with very slow flow fluid, but was not frozen. When the sample was left for 48 hours at −38° F., the sample was still was very thick with very slow flow, but still not frozen. After sitting at room temperature for about 7 minutes to 8 minutes after being left in the chiller for 48 hours, the sample was back to flowing the same as the 0° F. After the sample was in the chiller for 24 hours at 0° F., the sample was normal. After the sample was in the chiller for 24 hours at −20° F., the sample was very thick and very slow flow.
This example illustrates reusable high performance water based fluid having a density of 12.80 ppg. This fluid was prepared in accord with the preparation method of Example 1.
All references cited herein are incorporated by reference. Although the invention has been disclosed with reference to its preferred embodiments, from reading this description those of skill in the art may appreciate changes and modification that may be made which do not depart from the scope and spirit of the invention as described above and claimed hereafter.
This application claims the benefit of and provisional priority to U.S. Application Ser. No. 61/888,325 filed Oct. 8, 2013.
Number | Name | Date | Kind |
---|---|---|---|
2196042 | Timpson | Apr 1940 | A |
2390153 | Kern | Dec 1945 | A |
2805958 | Bueche et al. | Jul 1959 | A |
3059909 | Wise | Oct 1962 | A |
3163219 | Wyant et al. | Dec 1964 | A |
3301723 | Chrisp | Jan 1967 | A |
3301848 | Halleck | Jan 1967 | A |
3303896 | Tillotson et al. | Feb 1967 | A |
3317430 | Priestley et al. | May 1967 | A |
3565176 | Wittenwyler | Feb 1971 | A |
3856921 | Shrier et al. | Dec 1974 | A |
3888312 | Tiner et al. | Jun 1975 | A |
3933205 | Kiel | Jan 1976 | A |
3937283 | Blauer et al. | Feb 1976 | A |
3960736 | Free et al. | Jun 1976 | A |
3965982 | Medlin | Jun 1976 | A |
3990978 | Hill | Nov 1976 | A |
4007792 | Meister | Feb 1977 | A |
4052159 | Fuerst et al. | Oct 1977 | A |
4067389 | Savins | Jan 1978 | A |
4108782 | Thompon | Aug 1978 | A |
4112050 | Sartori et al. | Sep 1978 | A |
4112051 | Sartori et al. | Sep 1978 | A |
4112052 | Sartori et al. | Sep 1978 | A |
4113631 | Thompson | Sep 1978 | A |
4378845 | Medlin et al. | Apr 1983 | A |
4385935 | Skyeldal | May 1983 | A |
4461716 | Barbarin et al. | Jul 1984 | A |
4479041 | Fenwick et al. | Oct 1984 | A |
4506734 | Nolte | Mar 1985 | A |
4514309 | Wadhwa | Apr 1985 | A |
4541935 | Constien et al. | Sep 1985 | A |
4549608 | Stowe et al. | Oct 1985 | A |
4561985 | Glass, Jr. | Dec 1985 | A |
4623021 | Stowe | Nov 1986 | A |
4654266 | Kachnik | Mar 1987 | A |
4657081 | Hodge | Apr 1987 | A |
4660643 | Perkins | Apr 1987 | A |
4683068 | Kucera | Jul 1987 | A |
4686052 | Baranet et al. | Aug 1987 | A |
4695389 | Kubala | Sep 1987 | A |
4705113 | Perkins | Nov 1987 | A |
4714115 | Uhri | Dec 1987 | A |
4718490 | Uhri | Jan 1988 | A |
4724905 | Uhri | Feb 1988 | A |
4725372 | Teot et al. | Feb 1988 | A |
4739834 | Peiffer et al. | Apr 1988 | A |
4741401 | Walles et al. | May 1988 | A |
4748011 | Baize | May 1988 | A |
4779680 | Sydansk | Oct 1988 | A |
4780220 | Peterson | Oct 1988 | A |
4795574 | Syrinek et al. | Jan 1989 | A |
4817717 | Jennings, Jr. et al. | Apr 1989 | A |
4830106 | Uhri | May 1989 | A |
4846277 | Khalil et al. | Jul 1989 | A |
4848468 | Hazlett et al. | Jul 1989 | A |
4852650 | Jennings, Jr. et al. | Aug 1989 | A |
4869322 | Vogt, Jr. et al. | Sep 1989 | A |
4892147 | Jennings, Jr. et al. | Jan 1990 | A |
4926940 | Stromswold | May 1990 | A |
4938286 | Jennings, Jr. | Jul 1990 | A |
4978512 | Dillon | Dec 1990 | A |
5005645 | Jennings, Jr. et al. | Apr 1991 | A |
5024276 | Borchardt | Jun 1991 | A |
5067556 | Fudono et al. | Nov 1991 | A |
5074359 | Schmidt | Dec 1991 | A |
5074991 | Weers | Dec 1991 | A |
5076373 | Hale et al. | Dec 1991 | A |
5082579 | Dawson | Jan 1992 | A |
5106518 | Cooney et al. | Apr 1992 | A |
5110486 | Manalastas et al. | May 1992 | A |
5169411 | Weers | Dec 1992 | A |
5224546 | Smith et al. | Jul 1993 | A |
5228510 | Jennings, Jr. et al. | Jul 1993 | A |
5246073 | Sandiford et al. | Sep 1993 | A |
5259455 | Nimerick et al. | Nov 1993 | A |
5330005 | Card et al. | Jul 1994 | A |
5342530 | Aften et al. | Aug 1994 | A |
5347004 | Rivers et al. | Sep 1994 | A |
5363919 | Jennings, Jr. | Nov 1994 | A |
5465792 | Dawson et al. | Jan 1995 | A |
5402846 | Jennings, Jr. et al. | Apr 1995 | A |
5411091 | Jennings, Jr. | May 1995 | A |
5424284 | Patel et al. | Jun 1995 | A |
5439055 | Card et al. | Aug 1995 | A |
5462721 | Pounds et al. | Oct 1995 | A |
5472049 | Chaffe et al. | Dec 1995 | A |
5482116 | El-Rabaa et al. | Jan 1996 | A |
5488083 | Kinsey, III et al. | Jan 1996 | A |
5497831 | Hainey et al. | Mar 1996 | A |
5501275 | Card et al. | Mar 1996 | A |
5539044 | Dindi et al. | Jul 1996 | A |
5551516 | Norman et al. | Sep 1996 | A |
5624886 | Dawson et al. | Apr 1997 | A |
5635458 | Lee et al. | Jun 1997 | A |
5649596 | Jones et al. | Jul 1997 | A |
5669447 | Walker et al. | Sep 1997 | A |
5674377 | Sullivan, III et al. | Oct 1997 | A |
5686396 | Hale et al. | Nov 1997 | A |
5688478 | Pounds et al. | Nov 1997 | A |
5693837 | Smith et al. | Dec 1997 | A |
5711396 | Joerg et al. | Jan 1998 | A |
5722490 | Ebinger | Mar 1998 | A |
5744024 | Sullivan, III et al. | Apr 1998 | A |
5755286 | Ebinger | May 1998 | A |
5775425 | Weaver et al. | Jul 1998 | A |
5787986 | Weaver et al. | Aug 1998 | A |
5806597 | Tjon-Joe-Pin et al. | Sep 1998 | A |
5807812 | Smith et al. | Sep 1998 | A |
5833000 | Weaver et al. | Nov 1998 | A |
5853048 | Weaver et al. | Dec 1998 | A |
5871049 | Weaver et al. | Feb 1999 | A |
5877127 | Card et al. | Mar 1999 | A |
5908073 | Nguyen et al. | Jun 1999 | A |
5908814 | Patel et al. | Jun 1999 | A |
5964295 | Brown et al. | Oct 1999 | A |
5979557 | Card et al. | Nov 1999 | A |
5980845 | Cherry | Nov 1999 | A |
6001887 | Keup et al. | Dec 1999 | A |
6016871 | Burts, Jr. | Jan 2000 | A |
6035936 | Whalen | Mar 2000 | A |
6047772 | Weaver et al. | Apr 2000 | A |
6054417 | Graham et al. | Apr 2000 | A |
6059034 | Rickards et al. | May 2000 | A |
6060436 | Synder et al. | May 2000 | A |
6063972 | Duncum et al. | May 2000 | A |
6069118 | Hinkel et al. | May 2000 | A |
6123394 | Jeffrey | Sep 2000 | A |
6133205 | Jones | Oct 2000 | A |
6147034 | Jones et al. | Nov 2000 | A |
6162449 | Maier et al. | Dec 2000 | A |
6162766 | Muir et al. | Dec 2000 | A |
6169058 | Le et al. | Jan 2001 | B1 |
6228812 | Dawson et al. | May 2001 | B1 |
6247543 | Patel et al. | Jun 2001 | B1 |
6267938 | Warrender et al. | Jul 2001 | B1 |
6283212 | Hinkel et al. | Sep 2001 | B1 |
6291405 | Lee et al. | Sep 2001 | B1 |
6330916 | Rickards et al. | Dec 2001 | B1 |
6725931 | Nguyen et al. | Apr 2004 | B2 |
6756345 | Pakulski et al. | Jun 2004 | B2 |
6793018 | Dawson et al. | Sep 2004 | B2 |
6832650 | Nguyen et al. | Dec 2004 | B2 |
6875728 | Gupta et al. | Apr 2005 | B2 |
7055628 | Grainger et al. | Jun 2006 | B2 |
7186353 | Novak | Mar 2007 | B2 |
7268100 | Kippie et al. | Sep 2007 | B2 |
7350579 | Gatlin et al. | Apr 2008 | B2 |
7392847 | Gatlin et al. | Jul 2008 | B2 |
7517447 | Gatlin | Apr 2009 | B2 |
7565933 | Kippie et al. | Jul 2009 | B2 |
7566686 | Kippie et al. | Jul 2009 | B2 |
7700702 | Gaillard et al. | Apr 2010 | B2 |
7712535 | Venditto et al. | May 2010 | B2 |
7767628 | Kippie et al. | Aug 2010 | B2 |
7829510 | Gatlin et al. | Nov 2010 | B2 |
7886824 | Kakadjian et al. | Feb 2011 | B2 |
7915203 | Falana et al. | Mar 2011 | B2 |
7932214 | Zamora et al. | Apr 2011 | B2 |
7942201 | Ekstrand et al. | May 2011 | B2 |
7956017 | Galtin et al. | Jun 2011 | B2 |
7956217 | Falana et al. | Jun 2011 | B2 |
7971659 | Gatlin et al. | Jul 2011 | B2 |
7989404 | Kakadjian et al. | Aug 2011 | B2 |
7992653 | Zamora et al. | Aug 2011 | B2 |
8011431 | van Petegem et al. | Sep 2011 | B2 |
8028755 | Darnell et al. | Oct 2011 | B2 |
8034750 | Thompson et al. | Oct 2011 | B2 |
8084401 | Lukocs et al. | Dec 2011 | B2 |
8093431 | Falana et al. | Jan 2012 | B2 |
8097567 | Wilson, Jr. | Jan 2012 | B2 |
8141661 | Kakadjian et al. | Mar 2012 | B2 |
8158562 | Wilson, Jr. et al. | Apr 2012 | B2 |
8172952 | Wanner et al. | May 2012 | B2 |
8220546 | Kakadjian et al. | Jul 2012 | B2 |
8258339 | Falana et al. | Sep 2012 | B2 |
8273693 | Schwartz | Sep 2012 | B2 |
8287640 | Zamora et al. | Oct 2012 | B2 |
8362298 | Falana et al. | Jan 2013 | B2 |
8466094 | Kakadjian et al. | Jun 2013 | B2 |
8475585 | Zamora et al. | Jul 2013 | B2 |
8507412 | Lukocs et al. | Aug 2013 | B2 |
8507413 | Wilson, Jr. | Aug 2013 | B2 |
8524639 | Falana et al. | Sep 2013 | B2 |
8530394 | Gatlin et al. | Oct 2013 | B2 |
8563481 | Gatlin et al. | Oct 2013 | B2 |
8714283 | Gatlin et al. | May 2014 | B2 |
8728989 | Kakadjian et al. | May 2014 | B2 |
8772203 | Schwartz | Jul 2014 | B2 |
8794325 | Willberg | Aug 2014 | B2 |
8835364 | Thompson et al. | Sep 2014 | B2 |
8841240 | Kakadjian et al. | Sep 2014 | B2 |
8846585 | Falana et al. | Sep 2014 | B2 |
8851174 | Zamora et al. | Oct 2014 | B2 |
8871694 | Zamora et al. | Oct 2014 | B2 |
8899328 | Zamora et al. | Dec 2014 | B2 |
8932996 | Falana et al. | Jan 2015 | B2 |
8944164 | Veldman et al. | Feb 2015 | B2 |
8946130 | Zamora et al. | Feb 2015 | B2 |
8950493 | van Petegem et al. | Feb 2015 | B2 |
20020049256 | Bergeron, Jr. | Apr 2002 | A1 |
20020165308 | Kinniard et al. | Nov 2002 | A1 |
20030176293 | Schilling | Sep 2003 | A1 |
20030220204 | Baran, Jr. et al. | Nov 2003 | A1 |
20050045330 | Nguyen et al. | Mar 2005 | A1 |
20050092489 | Welton et al. | May 2005 | A1 |
20050137114 | Gatlin et al. | Jun 2005 | A1 |
20100252262 | Ekstrand et al. | Oct 2010 | A1 |
20100305010 | Falana et al. | Dec 2010 | A1 |
20100311620 | Kakadjian et al. | Dec 2010 | A1 |
20110001083 | Falana et al. | Jan 2011 | A1 |
20110011645 | Muller | Jan 2011 | A1 |
20110177982 | Ekstrand et al. | Jul 2011 | A1 |
20110240131 | Parker | Oct 2011 | A1 |
20120061086 | Willberg | Mar 2012 | A1 |
20120071367 | Falana et al. | Mar 2012 | A1 |
20120073813 | Zamora et al. | Mar 2012 | A1 |
20120097893 | Wanner et al. | Apr 2012 | A1 |
20120273206 | Zamora et al. | Nov 2012 | A1 |
20120279727 | Kakadjian et al. | Nov 2012 | A1 |
20120295820 | Falana et al. | Nov 2012 | A1 |
20120302468 | Falana et al. | Nov 2012 | A1 |
20120325329 | Schwartz | Dec 2012 | A1 |
20130081820 | Falana et al. | Apr 2013 | A1 |
20130096038 | Kim et al. | Apr 2013 | A1 |
20130130947 | Brannon | May 2013 | A1 |
20130175477 | Falana et al. | Jul 2013 | A1 |
20130270012 | Kakadjian et al. | Oct 2013 | A1 |
20130274151 | Kakadjian et al. | Oct 2013 | A1 |
20130312977 | Lembcke et al. | Nov 2013 | A1 |
20130331301 | Falana et al. | Dec 2013 | A1 |
20140087977 | Kim et al. | Mar 2014 | A1 |
20140128294 | Gatlin et al. | May 2014 | A1 |
20140128308 | Levey et al. | May 2014 | A1 |
20140166285 | Santra et al. | Jun 2014 | A1 |
20140262287 | Treybig et al. | Sep 2014 | A1 |
20140262319 | Treybig et al. | Sep 2014 | A1 |
20140303048 | Kakadjian et al. | Oct 2014 | A1 |
20140315763 | Kakadjian et al. | Oct 2014 | A1 |
20140318793 | van Petergem et al. | Oct 2014 | A1 |
20140318795 | Thompson, Sr. et al. | Oct 2014 | A1 |
20140323360 | Comarin et al. | Oct 2014 | A1 |
20140323361 | Livanec | Oct 2014 | A1 |
20140323362 | Falana et al. | Oct 2014 | A1 |
20150007989 | Tan et al. | Jan 2015 | A1 |
20150011440 | Zamora et al. | Jan 2015 | A1 |
20150051311 | Zamora et al. | Feb 2015 | A1 |
20150068747 | Hwang et al. | Mar 2015 | A1 |
20150072901 | Samuel et al. | Mar 2015 | A1 |
20150087561 | Falana et al. | Mar 2015 | A1 |
20150087562 | Falana et al. | Mar 2015 | A1 |
20150203742 | Reddy | Jul 2015 | A1 |
20160145487 | Alam | May 2016 | A1 |
Number | Date | Country |
---|---|---|
2125513 | Jan 1995 | CA |
4027300 | May 1992 | DE |
775376 | Oct 1954 | GB |
1073338 | Jun 1967 | GB |
2216574 | Oct 1989 | GB |
10001461 | Jun 1988 | JP |
08151422 | Nov 1996 | JP |
10110115 | Apr 1998 | JP |
2005194148 | Jul 2005 | JP |
WO 9856497 | Dec 1998 | WO |
WO2000043465 | Jul 2000 | WO |
WO 2009141308 | Nov 2009 | WO |
Entry |
---|
PCT ISR WO, Application for PCT/IB2014/065110,dated Feb. 13, 2015. |
Number | Date | Country | |
---|---|---|---|
20150096808 A1 | Apr 2015 | US |
Number | Date | Country | |
---|---|---|---|
61888325 | Oct 2013 | US |